Agios Pharmaceuticals, Inc. (AGIO): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

57.97M
Year ended 2025-12-31
+1.9%
3-year compound annual growth
-3.4%
5-year compound annual growth
69.00M2019-12-31: 59.99M2020-12-31: 69.00M2021-12-31: 60.45M2022-12-31: 54.79M2023-12-31: 55.65M2024-12-31: 57.89M2025-12-31: 57.97M57.97M
2019-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3157.97M+0.1%2026-02-12, From 2025-01-01
2024-12-3157.89M+4.0%2026-02-12, From 2024-01-01
2023-12-3155.65M+1.6%2026-02-12, From 2023-01-01
2022-12-3154.79M-9.4%2025-02-13, From 2022-01-01
2021-12-3160.45M-12.4%2024-02-15, From 2021-01-01
2020-12-3169.00M+15.0%2023-02-23, From 2020-01-01
2019-12-3159.99Mn/a2022-02-24, From 2019-01-01